Derma Sciences Inc.
Zoll reported record numbers in its top and bottom line for fiscal year 2011, sending its stock up 23 percent overnight.
Zoll shares were trading at $44.35 in the early afternoon today, up from last night’s $35.98 close.
The company’s 2011 sales hit a record high of $523.7 million, 18 percent higher than the $444 million posted last year.
Shares of BioMimetic Therapeutics Inc. (NSDQ:BMTI) continued their slide today after plummeting 35.3 percent yesterday to close at $8.66 on news of the FDA’s dim view of its Augment bone graft product.
MassDevice keeps a close eye on public medical device companies, tracking their quarterly sales and earnings reports. For the most recent filings, check out our Earnings Roundup, where we collect each quarter’s reports.
Here’s a quick rundown of a few releases over the past couple days:
Derma Sciences increases sales, but dips into red
Derma Sciences Inc. (OTC:DSCI) posted losses of $502,552, or 8 cents per diluted share, on sales of $15.1 million during the three months ended Sept. 30. That compares with profits of $139,603, or 3 cents per share, on sales of $12.9 million during the same period last year.